Related Experiment Video
Updated: May 16, 2026

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Subclinical cerebral edema in children with diabetic ketoacidosis randomized to 2 different rehydration protocols
Nicole S Glaser1, Sandra L Wootton-Gorges, Michael H Buonocore
1Department of Pediatrics, School of Medicine, University of California Davis, Davis, California, USA. nsglaser@ucdavis.edu
Insights
Intravenous fluid rates do not significantly impact vasogenic cerebral edema (CE) during diabetic ketoacidosis (DKA) treatment in children. This study quantified subclinical CE using MRI, finding no substantial difference between rapid and slow fluid administration rates.
Area of Science:
- Pediatric Endocrinology
- Neuroimaging
- Critical Care Medicine
Background:
- Diabetic ketoacidosis (DKA) in children can lead to vasogenic cerebral edema (CE).
- The influence of intravenous fluid administration rates on CE during DKA treatment remains unclear.
- Quantifying subclinical CE is crucial for understanding DKA treatment complications.
Purpose of the Study:
- To investigate the role of intravenous fluid rates in the development of subclinical vasogenic cerebral edema (CE) during diabetic ketoacidosis (DKA) treatment in children.
- To utilize magnetic resonance diffusion-weighted imaging to measure CE non-invasively.
- To compare CE severity in children receiving DKA treatment with different intravenous fluid infusion rates.
Main Methods:
- Children with DKA were randomized into two groups receiving intravenous fluids at either a rapid or slower rate.
- Diffusion-weighted imaging (DWI) was performed during DKA treatment (3-6 and 9-12 hours) and after recovery (≥72 hours).
- Apparent diffusion coefficient (ADC) values were calculated to quantify brain water content and assess CE severity.
Main Results:
- Mean brain ADC values were significantly higher during DKA treatment compared to post-recovery, confirming vasogenic CE.
- No significant differences in ADC elevation were observed between children receiving rapid versus slower intravenous fluid rates.
- The rate of fluid administration did not substantially influence the degree of subclinical CE.
Conclusions:
- The rate of intravenous fluid administration does not appear to be a major factor in the development of vasogenic cerebral edema during DKA treatment in children.
- Subclinical CE, indicated by ADC changes, occurs during DKA treatment.
- Further research may explore other contributing factors to CE in DKA.
Objective:
Previous studies show that vasogenic cerebral edema (CE) occurs during diabetic ketoacidosis (DKA) treatment in children, but the role of intravenous fluids in contributing to CE is unclear. We used magnetic resonance diffusion weighted imaging to quantify subclinical CE in children with DKA randomized to 2 intravenous fluid regimens.
Methods:
Children with DKA were randomized to receive fluids at a more rapid rate (n = 8) or a slower rate (n = 10), with all other aspects of DKA treatment kept identical. Children underwent diffusion weighted imaging 3 to 6 hours and 9 to 12 hours after beginning DKA treatment and after recovery from DKA (≥ 72 hours after beginning treatment). We calculated brain apparent diffusion coefficient (ADC) values as the average of measurements in the basal ganglia, thalamus, frontal white matter, and hippocampus and determined the mean brain ADC value during DKA treatment by averaging data from the 3- to 6-hour and 9- to 12-hour measurements. The difference in mean brain ADC between DKA treatment and postrecovery was used as an index of the severity of CE during DKA treatment.
Results:
Mean brain ADC values during DKA treatment were significantly higher than postrecovery values, consistent with vasogenic CE (842 ± 38 vs 800 ± 41 × 10(-6) mm(2)/second, P = .002). We did not detect significant differences in ADC elevation in children treated with more rapid versus slower rehydration (β coefficient 0.11 for 1 SD change in ADC, 95% confidence interval: -0.91 to 1.13).
Conclusions:
ADC changes during DKA treatment (reflective of vasogenic CE) do not appear to be substantially affected by the rate of intravenous fluid administration.
Related Concept Videos
Diabetic Ketoacidosis l: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
